Quantitative Clinical Pharmacology Input to SARS-CoV-2 Therapeutics Should Be Based on Robust Data. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1872
PubMed Identifier: 32348551
Publication URI: http://europepmc.org/abstract/MED/32348551
Type: Journal Article/Review
Volume: 108
Parent Publication: Clinical pharmacology and therapeutics
Issue: 2
ISSN: 0009-9236